Sage Mountain Advisors’s Boston Scientific BSX Stock Holding History

Sage Mountain Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,999	Closed	-$667K	–	326
2025 Q4	$667K	Sell	6,999 -52	-0.7%	-$5.1K	0.04%	228
2025 Q3	$688K	Sell	7,051 -629	-8%	-$65.1K	0.04%	215
2025 Q2	$825K	Buy	7,680 +44	+0.6%	+$4.45K	0.05%	170
2025 Q1	$770K	Buy	7,636 +219	+3%	+$22.1K	0.06%	156
2024 Q4	$663K	Buy	7,417 +822	+12%	+$72.4K	0.05%	170
2024 Q3	$553K	Sell	6,595 -192	-3%	-$15.1K	0.05%	185
2024 Q2	$523K	Buy	6,787 +2,247	+49%	+$164K	0.05%	170
2024 Q1	$311K	Buy	4,540 +580	+15%	+$37.3K	0.03%	230
2023 Q4	$229K	Buy	3,960 +49	+1%	+$2.62K	0.03%	242
2023 Q3	$207K	Buy	3,911 +102	+3%	+$5.35K	0.03%	243
2023 Q2	$206K	Buy	+3,809	New	+$199K	0.03%	245

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sage Mountain Advisors's BSX Position: Q1 2026 in Review

Sage Mountain Advisors sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 6,999 shares — an estimated $667K sold.

Sage Mountain Advisors first reported a position in BSX in Q2 2023 and held it in 11 quarters. The position peaked at $825K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Sage Mountain Advisors reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Sage Mountain Advisors sold 6,999 Boston Scientific shares in Q1 2026, an estimated $667K.
Sage Mountain Advisors first reported a position in Boston Scientific in Q2 2023 and held it in 11 quarters.
Sage Mountain Advisors's Boston Scientific position peaked at $825K in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Sage Mountain Advisors's 13F filing for Q1 2026, filed 11 May 2026.